Polymorphisms in TNF and IFNG are associated with clinical characteristics of aplastic anemia in Argentinean population

References

• Zeng W, Chen G, Kajigaya S, et al. Gene expression profiling in CD34 cells to identify differences between aplastic anemia patients and healthy volunteers. Blood 2004;103:325–332.
   PubMed Web of Science ®Google Scholar
• Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 2006;108:2509–2519.
   PubMed Web of Science ®Google Scholar
• Young NS, Maciejewski J. The pathophysiology of acquired aplastic anemia. N Engl J Med 2007;336:1365–1372.
   Google Scholar
• Shipounova IN, Petrova TV, Svinareva DA, et al. Alterations in hematopoietic microenvironment in patients with aplastic anemia. Clin Transl Sci 2009;2:67–74.
   PubMed Web of Science ®Google Scholar
• Maciejewski JP, Selleri C, Anderson S, et al. Fas antigen expression on CD34 + human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 1995;85:3183–3190.
   PubMed Web of Science ®Google Scholar
• Kook H, Risitano AM, Zeng W, et al. Changes in T-cell receptor VB repertoire in aplastic anemia: effects of different immunosuppressive regimens. Blood 2002;99:3668–3675.
   PubMed Web of Science ®Google Scholar
• Sloand E, Maciejewski JP, Tisdale J, et al. Intracellular Interferon-g (IFN-g) in circulating and marrow T cells detected by flow cytometry and the response to immunosuppressive therapy in patients with aplastic anemia. Blood 2002;100:3129–3135.
   Web of Science ®Google Scholar
• Giannakoulas NC, Karakantza M, Theodorou GL, et al. Clinical relevance of balance between type 1 and type 2 immune responses of lymphocyte subpopulations in aplastic anaemia patients. Br J Haematol 2004;124:97–105.
   PubMed Web of Science ®Google Scholar
• Rosenfeld S, Follmann D, Nunez O, et al. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA 2003;289: 1130–1135.
   PubMed Web of Science ®Google Scholar
• Locasciulli A, Oneto R, Bacigalupo A, et al. Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT). Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplant Group. Haematologica 2007;92:11–18.
   Google Scholar
• Pulsipher MA, Young NS, Tolar J, et al. Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network, March2010. Biol Blood Marrow Transplant2011;17:291–299.
   Google Scholar
• Huang HR, Zhong YQ, Wu JF. The association between IFN-γ and IL-4 genetic polymorphisms and childhood susceptibility to bronchial asthma. Gene 2012;494:96–101.
   PubMed Web of Science ®Google Scholar
• Waldron-Lynch F, Adams C, Amos C, et al. Tumour necrosis factor 5’ promoter single nucleotide polymorphisms influence susceptibility to rheumatoid arthritis (RA) in immunogenetically defined multiplex RA families. Genes Immun 2001;2:82–87.
   PubMed Web of Science ®Google Scholar
• Saunthararajah Y, Nakamura R, Nam JM, et al. HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome. Blood 2002;100:1570–1574.
   PubMed Web of Science ®Google Scholar
• Gidvani V, Ramkissoon S, Sloand EM, et al. Cytokine gene polymorphisms in acquired bone marrow failure. Am J Hematol 2007;82:721–724.
   PubMed Web of Science ®Google Scholar
• Kroeger KM, Carville KS, Abraham LJ. The − 308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 1997;34:391–399.
   PubMed Web of Science ®Google Scholar
• Pravica V, Asderakis A, Perrey C, et al. In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur J Immunogenet 1999;26:1–3.
   PubMedGoogle Scholar
• Pravica V, Perrey C, Stevens A, et al. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 2000;61:863–866.
   PubMed Web of Science ®Google Scholar
• Dufour C, Capasso M, Svahn J, et al. Homozygosis for (12) CA repeats in the first intron of the human IFN-gamma gene is significantly associated with the risk of aplastic anaemia in Caucasian population. Br J Haematol 2004;126:682–685.
   PubMed Web of Science ®Google Scholar
• Fermo E, Bianchi P, Barcellini W, et al. Immunoregulatory cytokine polymorphisms in Italian patients affected by paroxysmal nocturnal haemoglobinuria and aplastic anaemia. Eur J Immunogenet 2004;31:267–269.
   PubMedGoogle Scholar
• Belli CB, Bestach Y, Sieza Y, et al. The presence of -308A TNFα is associated with anemia and thrombocytopenia in patients with myelodysplastic syndromes. Blood Cells Mol Dis 2011;47:255–258.
   PubMed Web of Science ®Google Scholar
• Lee YG, Kim I, Kim JH, et al. Impact of cytokine gene polymorphisms on risk and treatment outcomes of aplastic anemia. Ann Hematol 2011;90:515–521.
   PubMed Web of Science ®Google Scholar
• Serio B, Selleri C, Maciejewski JP. Impact of immunogenetic polymorphisms in bone marrow failure syndromes. Mini Rev Med Chem 2011;11:544–552.
   PubMed Web of Science ®Google Scholar
• Parnes A, Nikiforow S, Berliner N, et al. Single nucleotide polymorphisms in the human TNF gene are associated with anaemia and neutropenia in a cohort of patients with de novo myelodysplastic syndrome. Br J Haematol 2010;150:700–701.
   PubMed Web of Science ®Google Scholar
• Demeter J, Messer G, Schrezenmeier H. Clinical relevance of the TNF-alpha promoter/enhancer polymorphism in patients with aplastic anemia. Ann Hematol 2002;81:566–569.
   PubMed Web of Science ®Google Scholar
• Camitta BM, Thomas ED, Nathan DG, et al. Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. Blood 1976;48:63–70.
   PubMed Web of Science ®Google Scholar
• Incidence of aplastic anaemia: the relevance of diagnostic criteria.By the International Agranulocytosis and Aplastic Anemia Study. Blood 1987;70:1718–1721.
   PubMedGoogle Scholar
• Yoshida N, Yagasaki H, Hama A, et al. Predicting response to immunosuppressive therapy in childhood aplastic anemia. Haematologica 2011;96:771–774.
   PubMed Web of Science ®Google Scholar
• Wilson AG, di Giovine FS, Blakemore AI, et al. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992;1:353.
   PubMedGoogle Scholar
• Maynard SJ. Evolutionary genetics. 2nd ed. Oxford: Oxford University Press; 1998.
   Google Scholar
• Feng X, Scheinberg P, Wu CO, et al. Cytokine signature profiles in acquired aplastic anemia and myelodysplastic syndromes. Haematologica 2011;96:602–606.
   PubMed Web of Science ®Google Scholar
• International HapMap Project. Available from: http://hapmap.ncbi.nlm.nih.gov/
   Google Scholar
• National Centre of Biotechnology Information SNP database. Available from: www.ncbi.nlm.nih.gov/projects/SNP/
   Google Scholar
• Carlo-Stella N, Badulli C, De Silvestri A, et al. A first study of cytokine genomic polymorphisms in CFS: positive association of TNF-857 and IFNgamma 874 rare alleles. Clin Exp Rheumatol 2006;24:179–182.
   PubMed Web of Science ®Google Scholar
• Chinoy H, Salway F, John S, et al. Interferon-gamma and interleukin-4 gene polymorphisms in Caucasian idiopathic inflammatory myopathy patients in UK. Ann Rheum Dis 2007;66: 970–973.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gay MA, Hajeer AH, Dababneh A, et al. Interferon-gamma gene microsatellite polymorphisms in patients with biopsy-proven giant cell arteritis and isolated polymyalgia rheumatica. Clin Exp Rheumatol 2004;22(Suppl. 36):S18–S20.
   Google Scholar
• Horie Y, Kitaichi N, Takemoto Y, et al. Polymorphism of IFN-gamma gene and Vogt-Koyanagi-Harada disease. Mol Vis 2007; 13:2334–2338.
   PubMed Web of Science ®Google Scholar
• Heinemeyer T, Wingender E, Reuter I, et al. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 1998;26:362–367.
   PubMed Web of Science ®Google Scholar